• OM-MSCs, Golgi Stress, and Stroke Recovery

  2026-08-26

  This study identifies Golgi apparatus stress as a modifiable component of cerebral ischemia/reperfusion injury and shows that olfactory mucosa mesenchymal stem cells reduce this response through PEDF-associated PI3K/Akt/mTOR signaling. Its combined cellular and animal models connect organelle protection, calcium and oxidative stress control, and autophagy regulation, providing a mechanistic framework for evaluating OM-MSC-based neuroprotection.

• Amikacin Sulfate: From MIC to Granuloma Targeting

  2026-08-26

  Amikacin Sulfate is more than a conventional aminoglycoside: its activity, intracellular exposure, and tissue-directed delivery can be evaluated as separate experimental variables. This guide translates granuloma-targeting research into practical assay and study-design decisions.

• AG-126 (Tyrphostin AG-126) Assay Guide

  2026-08-25

  Learn how AG-126 (Tyrphostin AG-126), SKU C4338, can strengthen ERK-focused viability, proliferation, and cytotoxicity workflows without confusing pathway inhibition with cell death. This scenario-based guide covers concentration design, solvent controls, interpretation, handling, and evidence-based product selection.

• Lysis Buffer for Faster Mouse Genotyping

  2026-08-25

  Turn small tail, toe, or ear biopsies into a practical DNA input for mouse genotyping with a workflow built around controlled proteinase K digestion. This guide connects reliable colony genotyping with the experimental design lessons of a 2026 colorectal cancer transcriptomics study—while clearly separating validated product use from translational hypotheses.

• Clasto-Lactacystin β-lactone in RIPK3 Assays

  2026-08-24

  Explore how Clasto-Lactacystin β-lactone can turn proteasome inhibition into a causal assay for viral RIPK3 degradation and necroptosis. This mechanistic framework complements conventional viability workflows by clarifying controls, readouts, and interpretation limits.

• Epirubicin Targets B56δ to Limit Kidney Fibrosis

  2026-08-24

  The reference study identifies epirubicin as a small-molecule inhibitor of the PP2A regulatory subunit B56δ and links this intervention to reduced lipid accumulation and fibrosis in obstructive kidney disease models. Its main contribution is to shift therapeutic attention from the broadly active PP2A catalytic subunit toward a more selective regulatory component, while the findings remain preclinical and require additional mechanistic and safety validation.

• Acridine Orange hydrochloride: Practical Staining Guide

  2026-08-23

  Acridine Orange hydrochloride provides membrane-permeable, dual-channel nucleic acid staining for workflows that need context-dependent green and red fluorescence, including cell cycle analysis, apoptosis detection, and flow cytometry. It should be method-validated for each cell model and is not a substitute for sequence-specific nucleic acid assays, standalone apoptosis diagnosis, or long-term storage of prepared solutions.

• Doxycycline in AAA Research: Workflow & Optimization

  2026-08-22

  Doxycycline combines tetracycline antibiotic activity with metalloproteinase inhibition, making it useful for mechanistic studies of vascular remodeling, cancer-cell proliferation, and antimicrobial responses. This guide translates a targeted AAA nanomedicine study into practical assay designs, dosing controls, and troubleshooting decisions for free-drug experiments and delivery-platform comparisons.

• Deferoxamine Mesylate in Lysosomal Stress

  2026-08-22

  Deferoxamine mesylate is an iron-chelating agent that can help dissect how iron availability intersects with lysosomal stress during glucose starvation. This article translates the TCF25–V-ATPase–ferritinophagy findings of a 2025 Cell Reports study into practical assay decisions while defining the compound’s limits.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-08-21

  Use a fluorescein-conjugated secondary antibody to convert rabbit-primary immunoassays into sensitive, imageable readouts for HMGB1 validation. This practical workflow covers immunofluorescence, flow cytometry, tissue imaging, storage, controls, and troubleshooting for diabetic nephropathy research.

• Aconitase Activity Colorimetric Assay Kit Workflow

  2026-08-20

  Turn aconitase activity into a practical readout for oxidative damage, mitochondrial dysfunction, and immunometabolic studies. This workflow combines 450 nm colorimetry, disciplined sample handling, and orthogonal validation to distinguish altered enzyme function from changes in protein abundance.

• Coronavirus Macrodomain–PARP Antiviral Defense

  2026-08-20

  The reference study shows that coronavirus macrodomains counter a host antiviral pathway driven by PARP12 and PARP14. By combining macrodomain-mutant viruses, pharmacological inhibition, gene knockdown, and macrophage and animal models, the authors connect ADP-ribosylation with both viral restriction and interferon regulation.

• CD28–ARS2 Rewires PKM Splicing in CD8+ T Cells

  2026-08-19

  The reference study identifies a CD28–ARS2 signaling axis that alters alternative splicing of PKM, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings connect costimulatory signaling to RNA processing, glucose utilization, interferon-γ production, and antitumor activity while revealing a mechanism that operates independently of the canonical CD28–PI3K pathway.

• Sisomicin Activity Against Clinical Isolates

  2026-08-19

  Stewart and Bodey evaluated sisomicin against 565 clinical isolates and showed activity broadly comparable to gentamicin and tobramycin, with greater potency than kanamycin and butirosin against tested gram-negative bacilli. The study also identified an important cross-resistance pattern: isolates resistant to gentamicin and tobramycin were generally resistant to sisomicin, whereas many remained susceptible to amikacin.

• Phosbind Biotin LC Western Blot Guide

  2026-08-18

  Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes without relying on a sequence-specific phospho-antibody. It is intended for membrane-based Western Blot workflows with streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of working solutions.

8514 records 1/568 page Next 12345 下5页 Last page